In conclusion, substantial progress has been made in the development of the PMN platform technology in the past few years.
From multiple angles the prospects for commercializing the technology look good. The technology is promising for biomaterials
development, and it has good potential to influence development of a variety of approaches to drug delivery. The technology
could also be useful for development of multifunctional biomaterials. For instance, a variety of bioactive peptides could
be used simultaneously to functionalize a PMN for different purposes, or various drugs could be encapsulated simultaneously
for co-delivery. It is possible that other basic themes for technology development have yet to be identified. It is certain
in any case that many variations on the known themes wait to be explored.
Donald T. Haynie, PhD , is vice-president of research and chief scientific officer at Artificial Cell Technologies, Inc., 5 Science Park at Yale,
New Haven, CT 06511, tel. 1 203.772.3430, firstname.lastname@example.org
1. A. Samad et al., "Liposomal Drug Delivery Systems: An Update Review," Curr. Drug Deliv. 4, 297–305 (2008).
2. C. Nastruzzi, Lipospheres in Drug Targets and Delivery: Approaches, Methods, and Applications (Taylor & Francis, London, 2007).
3. K. Kataoka et al., "Block Copolymer Micelles for Drug Delivery: Design, Characterization and Biological Significance," Adv. Drug Deliv. Rev. 47, 113–131 (2001).
4. A.S. Hoffman, "Hydrogels for Biomedical Applications," Adv. Drug Deliv. Rev. 54, 3–12 (2002).
5. M.J. Lawrence and G.D. Rees, "Microemulsion-based Media as Novel Drug Delivery Systems," Adv. Drug Deliv. Rev. 45, 89–121 (2000).
6. H.L. Crampton and E.E. Simanek, "Dendrimers and Drug Delivery Vehicles: Non-Covalent Interactions of Bioactive Compounds
with Dendrimers," Polym. Int. 56, 489–496 (2007).
7. R. Challa et al., "Cyclodextrins in Drug Delivery: An Updated Review," AAPS Pharm. Sci. Tech. 6, E329–E357 (2005).
8. L. Liu et al., "Pectin in Controlled Drug Delivery—A Review," Cellulose 14,15–24(2007).
9. P.P. Constantinides et al., "Advances in the Use of Tocols as Drug Delivery Vehicles," Pharm. Res. 23, 243–255, (2006).
10. S. Svenson, ed., Polymeric Drug Delivery I: Particular Drug Carriers (American Chemical Society, Washington, DC, 2006).
11. C. Alexander, "Theme Issue: Biomedical Materials," J. Mater. Chem. 17, 3963–3964 (2007).
12. J.S. Temenoff and A.G. Mikos, Biomaterials: The Intersection of Biology and Materials Science (Englewood Cliffs, New Jersey: Prentice-Hall, 2008).
13. J.M. Anderson and M.S. Shive, "Biodegradation and Biocompatibility of PLA and PLGA Microspheres," Adv. Drug Deliv. Rev. 28, 5–24 (1997).
14. D.T. Haynie et al., "Polypeptide Multilayer Films," Biomacromolecules 6, 2895–2913 (2005).
15. T.M. Cooper et al., "Preparation of Polypeptide-Dye Multilayers by an Electrostatic Assembly Process," Mater. Res. Soc. Symp. Proc. 351, 239–244 (1994).